Wearable devices can reduce cardiovascular events and death in ischemic heart disease, according to a new meta-analysis, but ...
The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute myocardial infarction (AMI) and unstable angina, an aging global population ...
The drug Enoxaparin is used for anti-coagulation once there is clot formation in any part of the body. More commonly, it’s ...
unstable angina, and non-Q-wave myocardial infarction. Standard doses still are recommended for patients with milder degrees of renal impairment. Thorevska N et al. Anticoagulation in hospitalized ...
The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute myocardial infarction (AMI) and unstable angina, an aging global population, ...
The Society for Simulation in Healthcare (SSH) has announced that Jared Kutzin, DNP, MS, MPH, RN, CHSOS, FSSH, FAAN, has become the 20th President of the Society. His term began at the completion of ...
Note: This is the second article in a two-part series with Brooke Struck, CEO of Converge, on cultivating stable leadership in unstable times. To explore the foundation for this leadership ...
Acute coronary syndromes are sudden episodes of reduced or no blood flow and therefore oxygen delivery to part of the heart, usually as a result of narrowing or blockage of an artery. The ...
Cycle Pharmaceuticals, Inc. (Cycle) announces today completion of the acquisition of Banner Life Sciences, LLC (Banner) which includes its BAFIERTAM ® (monomethyl fumarate) product for the treatment ...
New York, USA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Myocardial Infarction Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
Cycle Pharmaceuticals, Inc. (Cycle) announces today completion of the acquisition of Banner Life Sciences, LLC (Banner) which includes its BAFIERTAM (monomethyl fumarate) product for the treatment of ...